drugset / Trial / NCT00822237
Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)
RandomizedParallel-groupTriple-blindPrevention
Summary
This study will test the safety, tolerability, and immunogenicity of VARIVAX manufactured with the 2007 commercial Varicella-Zoster Virus (VZV) bulk process when concomitantly administered with M-M-R II in healthy children.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-10
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Varivax | Vaccine | 0.5 ml | Other |
| Background | Measles, Mumps, and Rubella Virus Vaccine Live (MMR) | Vaccine | 0.5 ml | Other |